A surge in ER visits and hospitalization rates on the part of newly-insured Medicaid patients is a mostly temporary phenomenon created by pent-up demand, according to a report by UCLA’s Center for Health Policy Research.
A surge in ER visits and hospitalization rates on the part of newly-insured Medicaid patients is a mostly temporary phenomenon created by pent-up demand, according to a report by UCLA’s Center for Health Policy Research (HPR).
The study, released October 21, eases fears that large numbers of new Medicaid patients would overwhelm the system and strain budgets.
As of July 2014, California had logged 1.5 million new Medicaid enrollees due to the state’s decision to expand Medicaid as part of the Affordable Care Act. That number includes 650,000 who were transitioned from the state’s Low-Income Health Program (LIHP).
The study looked at claims data from two consecutive Medicaid-voucher programs in California, the Health Care Coverage Initiative (HCCI), which ran from September 2007 to October 2010, and LIHP, which ran from July 2011 to December 2013.
Both provided coverage to individuals who were not eligible for Medi-Cal or other low-income programs at the time, and who would have been eligible for Medicaid under Medicaid expansion.
Results were that those individuals with the highest pent-up demand initially had 600 emergency room visits for 1,000 enrollees, but the rate quickly dropped and then remained relatively constant, eventually falling to 183 out of 1,000 individuals during the second year of analysis.
The next highest-demand group showed a significantly smaller initial number of visits that then remained constant, and the lowest-demand group had a had a smaller number of initial visits that remained constant.
READ: Costs drive Medicaid's reality
Hospitalization rates among those with the highest pent-up demand followed a similar trend, spiking at first and then rapidly declining.
Outpatient visits among all enrollees – those with the highest and lowest pent-up demand – remained fairly constant over the two-year study period.
The report notes that ER use and hospitalization rates fell to numbers comparable to previously insured populations with access to comprehensive care.
"We believe Medicaid expansion is sustainable because the initial high cost of newly enrolled beneficiaries does not persist beyond the first year of enrollment for the vast majority of new enrollees," Gerald F. Kominski, Ph.D., director of the HPR, told Managed Healthcare Exective.
The report, “suggest that the higher costs and utilization among newly enrolled Medicaid beneficiaries is a temporary rather than permanent phenomenon.” Authors note that policymakers and service providers can expect a reduction in demand for high-cost services after the first year of Medicaid enrollment.”
FDA Site Inspections Decreased During Pandemic. Questions Continue about Drug Quality.
December 4th 2023A recent study has found that FDA inspections of drug manufacturing facilities have increased since the COVID-19 health emergency but have not yet returned to pre-pandemic numbers.
Read More
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
RSV Vaccines for Adults: Gaps in Understanding
December 4th 2023Angela Branche, M.D., an infectious disease specialist at the University of Rochester School of Medicine, says the gaps are in a precise understanding of who is at risk for serious illness from respiratory syncytial virus and therefore who should get vaccinated.
Read More
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen